AU3192500A - Substituted proline derivatives and medicinal compositions containing the same - Google Patents

Substituted proline derivatives and medicinal compositions containing the same

Info

Publication number
AU3192500A
AU3192500A AU31925/00A AU3192500A AU3192500A AU 3192500 A AU3192500 A AU 3192500A AU 31925/00 A AU31925/00 A AU 31925/00A AU 3192500 A AU3192500 A AU 3192500A AU 3192500 A AU3192500 A AU 3192500A
Authority
AU
Australia
Prior art keywords
same
compositions containing
medicinal compositions
proline derivatives
substituted proline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31925/00A
Inventor
Tsuyoshi Haneishi
Masayuki Haramura
Takuya Shiraishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C&C Research Laboratories
Original Assignee
C & C Res Lab
C&C Research Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C & C Res Lab, C&C Research Laboratories filed Critical C & C Res Lab
Publication of AU3192500A publication Critical patent/AU3192500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU31925/00A 1999-03-16 2000-03-16 Substituted proline derivatives and medicinal compositions containing the same Abandoned AU3192500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/70634 1999-03-16
JP7063499 1999-03-16
PCT/JP2000/001598 WO2000055188A1 (en) 1999-03-16 2000-03-16 Substituted proline derivatives and medicinal compositions containing the same

Publications (1)

Publication Number Publication Date
AU3192500A true AU3192500A (en) 2000-10-04

Family

ID=13437281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31925/00A Abandoned AU3192500A (en) 1999-03-16 2000-03-16 Substituted proline derivatives and medicinal compositions containing the same

Country Status (3)

Country Link
KR (1) KR20020004971A (en)
AU (1) AU3192500A (en)
WO (1) WO2000055188A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114004D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
GB0114005D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
US11584714B2 (en) 2018-05-29 2023-02-21 Omeros Corporation MASP-2 inhibitors and methods of use
SG11202010925UA (en) * 2018-05-29 2020-12-30 Omeros Corp Masp-2 inhibitors and methods of use
CN110498808B (en) * 2019-09-16 2021-11-05 浙江晖石药业有限公司 Intermediate for synthesizing (2S,3R) -3-substituted phenyl pyrrolidine-2-carboxylic acid and preparation method and application thereof
IL293550A (en) 2019-12-04 2022-08-01 Omeros Corp Masp-2 inhibitor compounds, compositions comprising same and uses thereof
IL293551A (en) 2019-12-04 2022-08-01 Omeros Corp Masp-2 inhibitor compounds, compositions comprising same and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
US5827866A (en) * 1995-06-07 1998-10-27 Ortho Pharmaceutical Corporation Peptidyl heterocycles useful in the treatment of thrombin related disorders

Also Published As

Publication number Publication date
WO2000055188A1 (en) 2000-09-21
KR20020004971A (en) 2002-01-16

Similar Documents

Publication Publication Date Title
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL151372A0 (en) Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
IL156558A0 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
AU3192700A (en) Medicinal compositions
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2005300A (en) Medicinal compositions
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
AU1887401A (en) Medicinal composition
AU7651100A (en) Pharmaceutical and/or cosmetical compositions
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0200088A3 (en) Pyridazin-3-one derivatives and pharmaceutical compositions containing the same
AU6229099A (en) Dihydropyridine derivatives and drug compositions containing the same
AU1152601A (en) Compositions and their use
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
AU6016000A (en) Tricyclic compounds and drug compositions containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase